Trials / Completed
CompletedNCT00275925
Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures
A 24-Week Prospective, Open-Label, Multicenter Study to Evaluate the Effect on Seizure Frequency, Safety and Tolerability of Oxcarbazepine Monotherapy in Adult Patients With Partial Seizures
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 80 (planned)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- —
Summary
This study is aimed to evaluate the efficacy, safety and tolerability of oxcarbazepine monotherapy in adults with partial seizures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxcarbazepine |
Timeline
- Start date
- 2005-12-01
- Completion
- 2007-03-01
- First posted
- 2006-01-12
- Last updated
- 2007-11-30
Locations
7 sites across 1 country: Russia
Source: ClinicalTrials.gov record NCT00275925. Inclusion in this directory is not an endorsement.